Nonmyeloablative bone marrow transplantation based on deletion of host-anti-donor alloreactive cells prevents autoimmune insulitis and diabetes in nonobese diabetic mice.
Elkin
G
G
Department of Bone Marrow Transplantation,The Cancer Immunotherapy & Cancer Immunobiology Research Center, Hadassah University Hospital, Jerusalem, Israel.
Prighozina
T B
TB
Gurevitch
O
O
Slavin
S
S
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology*; D001786:Blood Glucose / Q000378:metabolism; D016026:Bone Marrow Transplantation / Q000276:immunology* / Q000379:methods; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000276:immunology / Q000601:surgery*; D007518:Isoantibodies / Q000276:immunology*; D008212:Lymphocyte Depletion; D051379:Mice; D008810:Mice, Inbred C57BL; D016688:Mice, Inbred NOD; D010182:Pancreatic Diseases / Q000276:immunology*; D018183:Transplantation Chimera; D014184:Transplantation, Homologous / Q000276:immunology
D001786:Blood Glucose; D007518:Isoantibodies